USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION

(19)

(11)

EP 1 948 237 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	22.02.2012 Bulletin 2012/08

(45)	Mention of the grant of the patent:
	04.05.2011 Bulletin 2011/18

(21)	Application number: 05784461.5

(22)	Date of filing: 10.08.2005

(51)

International Patent Classification (IPC):

A61K 45/06^(2006.01)
A61K 31/716^(2006.01)

A61K 31/715^(2006.01)
A61K 31/736^(2006.01)

(86)	International application number:
	PCT/US2005/028529

(87)	International publication number:
	WO 2007/021262 (22.02.2007 Gazette 2007/08)

(54)

USE OF ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, DIATOMACEOUS EARTH, MINERAL CLAY AND GLUCOMANNAN TO AUGMENT IMMUNE FUNCTION

VERWENDUNG VON - ß-1,3 (4)-ENDOGLUCANOHYDROLASE, ß-1,3 (4) GLUCAN, KIESELGUR, MINERALTON UND GLUCOMANNAN ZUR STEIGERUNG DER IMMUNFUNKTION

EMPLOI DE ß-1,3(4)-ENDOGLUCANOHYDROLASE, DE ß-1,3(4)-GLUCANE, DE TERRE DIATOMÉE, D'ARGILE MINÉRALE ET DE GLUCOMANNANE POUR AMÉLIORER LA FONCTION IMMUNITAIRE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
	Designated Extension States:
	AL BA HR MK YU

(43)	Date of publication of application:
	30.07.2008 Bulletin 2008/31

(73)	Proprietor: Omnigen Research, LLC
	Corvallis OR 97330 (US)

(72)	Inventors:
	Puntenney, Steven Bruce Independence OR 97351-9434 (US) Forsberg, Neil Elliott Independence OR 97351-9434 (US)

(74)	Representative: Prins, Hendrik Willem
	Arnold & Siedsma PO Box 18558 2502 EN The Hague 2502 EN The Hague (NL)

(56)

References cited: :

WO-A-95/30022
US-A1- 2002 048 573

WO-A-97/02356

DATABASE WPI Section Ch, Week 200002 Derwent Publications Ltd., London, GB; Class B06, AN 2000-021619 XP002359382 & RU 2 115 421 C1 (DEVICHENSKII V M) 20 July 1998 (1998-07-20)
DATABASE WPI Section Ch, Week 199824 Derwent Publications Ltd., London, GB; Class B06, AN 1998-269963 XP002359383 & RU 2 093 162 C1 (AS SIBE BIOCHEM INST) 20 October 1997 (1997-10-20)

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).